• Home
  • International Journal of Chemical and Biochemical Sciences (IJCBS) – HOME PAGE
  • Editorial board
  • Instructions to authors
  • Volume 30 (2026)
    • Volume 30 (Issue 24)
  • Volume 29 (2026)
    • Volume 29 (Issue 23)
  • Volume 28 (2025)
    • Volume 28 (Issue 22)
  • Volume 27 (2025)
    • Volume 27 (Issue 21)
  • Volume 26 (2024)
    • Volume 26 (Issue 20)
  • Volume 25 (2024)
    • Volume 25 (Issue 19)
    • Volume 25 (Issue 18)
    • Volume 25 (Issue 17)
    • Volume 25 (Issue 16)
    • Volume 25 (Issue 15)
    • Volume 25 (Issue 14)
    • Volume 25 (Issue 13)
  • Volume 24 (2023)
  • Volume 23 (2023)
  • Volume 22 (2022)
  • Volume 21 (2022)
  • Volume 20 (2021)
  • Volume 19 (2021)
  • Volume 18 (2020)
  • Volume 17 (2020)
  • Volume 16 (2019)
  • Volume 15 (2019)
  • Volume 14 (2018)
  • Volume 13 (2018)
  • Volume 12 (2017)
  • Volume 11 (2017)
  • Volume 10 (2016)
  • Volume 9 (2016)
  • Volume 8 (2015)
  • Volume 7 (2015)
  • Volume 6 (2014)
  • Volume 5 (2014)
  • Volume 4 (2013)
  • Volume 3 (2013)
  • Volume 2 (2012)
  • Volume 1 (2012)
International Scientific Organization International Scientific Organization

International Journal of Chemical and Biochemical Sciences (ISSN 2226-9614)[/vc_column_text][/vc_column][/vc_row]

Start New Submission

 

VOLUME 29(24) (2026)

Prevalence of Long COVID Symptoms After SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis

Rasha Sayed Mohamed, Issam Alsaed Barrimah, Hussain Aamar

Department of Community Medicine, Faculty of Medicine, Suez Canal University, Egypt.

Abstract

            Long COVID (post-acute sequelae of SARS-CoV-2 infection, PASC) is a multisystem condition characterized by persistent symptoms beyond the acute phase of infection. To estimate the global prevalence of long COVID symptoms and describe the most frequent symptom domains among adults with prior SARS-CoV-2 infection. A systematic review and meta-analysis conducted according to PRISMA guidelines. PubMed, Embase, Scopus, Web of Science, and the Cochrane Library were searched for studies published between January 2020 and December 2025 that reported post-acute symptoms ≥4 weeks after confirmed or suspected SARS-CoV-2 infection in adults.  Pooled prevalence was calculated using a random-effects model with inverse-variance weighting, and heterogeneity was assessed with the I² statistic. Eleven studies met the inclusion criteria; 11 provided sufficient data for meta-analysis after exclusion of pediatric cohorts, studies for clinical investigation and treatment. The pooled prevalence of any long COVID symptom was approximately 60% in adult populations, with estimates ranging from 48% to 73% across studies and substantial heterogeneity related to setting and follow-up duration. Fatigue, dyspnea, cognitive dysfunction, chest pain, sleep disturbances, anxiety, and depression were consistently the most prevalent symptom clusters. Long COVID symptoms affect a considerable proportion of adults after SARS-CoV-2 infection, with fatigue and respiratory complaints predominating. Standardized case definitions, harmonized follow-up protocols, and robust surveillance systems are needed to refine prevalence estimates and to support health-system planning.

Keywords: long COVID; prevalence; SARS-CoV-2; post-acute sequelae; systematic review; meta-analysis.

Review article             *Corresponding Author, e-mail: drrasha411@gmail.com; Doi # https://doi.org/10.62877/4-IJCBS-26-30-24-4

Submitted: 05-09-2026; Accepted: 08-10-2026; Published: 10-10-2026

International Scientific Organization- Atom to Universe

International Scientific Organization

  • Home
  • International Journal of Chemical and Biochemical Sciences (IJCBS) – HOME PAGE
  • Editorial board
  • Instructions to authors
  • Volume 30 (2026)
    • Volume 30 (Issue 24)
  • Volume 29 (2026)
    • Volume 29 (Issue 23)
  • Volume 28 (2025)
    • Volume 28 (Issue 22)
  • Volume 27 (2025)
    • Volume 27 (Issue 21)
  • Volume 26 (2024)
    • Volume 26 (Issue 20)
  • Volume 25 (2024)
    • Volume 25 (Issue 19)
    • Volume 25 (Issue 18)
    • Volume 25 (Issue 17)
    • Volume 25 (Issue 16)
    • Volume 25 (Issue 15)
    • Volume 25 (Issue 14)
    • Volume 25 (Issue 13)
  • Volume 24 (2023)
  • Volume 23 (2023)
  • Volume 22 (2022)
  • Volume 21 (2022)
  • Volume 20 (2021)
  • Volume 19 (2021)
  • Volume 18 (2020)
  • Volume 17 (2020)
  • Volume 16 (2019)
  • Volume 15 (2019)
  • Volume 14 (2018)
  • Volume 13 (2018)
  • Volume 12 (2017)
  • Volume 11 (2017)
  • Volume 10 (2016)
  • Volume 9 (2016)
  • Volume 8 (2015)
  • Volume 7 (2015)
  • Volume 6 (2014)
  • Volume 5 (2014)
  • Volume 4 (2013)
  • Volume 3 (2013)
  • Volume 2 (2012)
  • Volume 1 (2012)
INTERNATIONAL SCIENTIFIC ORGANIZATION- works with scientific research aim "atom to universe" Join us
Highend Church

©INTERNATIONAL SCIENTIFIC ORGANIZATION

  • Home
  • International Journal of Chemical and Biochemical Sciences (IJCBS) – HOME PAGE
  • Editorial board
  • Instructions to authors
  • Volume 30 (2026)
    • Volume 30 (Issue 24)
  • Volume 29 (2026)
    • Volume 29 (Issue 23)
  • Volume 28 (2025)
    • Volume 28 (Issue 22)
  • Volume 27 (2025)
    • Volume 27 (Issue 21)
  • Volume 26 (2024)
    • Volume 26 (Issue 20)
  • Volume 25 (2024)
    • Volume 25 (Issue 19)
    • Volume 25 (Issue 18)
    • Volume 25 (Issue 17)
    • Volume 25 (Issue 16)
    • Volume 25 (Issue 15)
    • Volume 25 (Issue 14)
    • Volume 25 (Issue 13)
  • Volume 24 (2023)
  • Volume 23 (2023)
  • Volume 22 (2022)
  • Volume 21 (2022)
  • Volume 20 (2021)
  • Volume 19 (2021)
  • Volume 18 (2020)
  • Volume 17 (2020)
  • Volume 16 (2019)
  • Volume 15 (2019)
  • Volume 14 (2018)
  • Volume 13 (2018)
  • Volume 12 (2017)
  • Volume 11 (2017)
  • Volume 10 (2016)
  • Volume 9 (2016)
  • Volume 8 (2015)
  • Volume 7 (2015)
  • Volume 6 (2014)
  • Volume 5 (2014)
  • Volume 4 (2013)
  • Volume 3 (2013)
  • Volume 2 (2012)
  • Volume 1 (2012)